ENTITY

OliX Pharmaceuticals (226950 KS)

4
Analysis
Health CareSouth Korea
OliX Pharmaceuticals, Inc. operates as a biotechnology and pharmaceutical company. The Company develops ribonucleic acid interference technology, ribonucleic acid interference therapeutics, and pharmaceuticals the treatment of macular degeneration. OliX Pharmaceuticals offers services throughout South Korea.
more
Presentation Icon
No presentations found
We’ll display presentations we find for OliX Pharmaceuticals here
x